Top compounds associated with response to ARSG


Feature Type Standardized
Nominal ANOVA
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.016 0.7
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.7
mRNA myricetin CTRPv2 pan-cancer AAC -0.015 0.7
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.014 0.7
mRNA BRD-K78574327 CTRPv2 pan-cancer AAC 0.028 0.7
mRNA CIL55 CTRPv2 pan-cancer AAC 0.023 0.7
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA semagacestat CTRPv2 pan-cancer AAC -0.014 0.7
mRNA CD-437 CTRPv2 pan-cancer AAC 0.012 0.7
mRNA Curcumin CTRPv2 pan-cancer AAC 0.013 0.7
Download CSV